KLOTHO Allele Status and the Risk of Early-onset Occult Coronary Artery Disease
Overview
Authors
Affiliations
We previously identified a functional variant of KLOTHO (termed "KL-VS"), which harbors two amino acid substitutions in complete linkage disequilibrium and is associated with reduced human longevity when in homozygosity. Klotho-deficient mice display extensive arteriosclerosis when fed a normal diet, suggesting a potent genetic predisposition. To determine whether klotho influences atherosclerotic risk in humans, we performed cross-sectional studies to assess the association between the KL-VS allele and occult coronary artery disease (CAD) in two independent samples of apparently healthy siblings of individuals with early-onset (age <60 years) CAD (SIBS-I [N=520] and SIBS-II [N=436]). Occult CAD was defined as the occurrence of a reversible perfusion defect during exercise thallium scintigraphy and/or as an abnormal result of an exercise electrocardiogram (SIBS-I, n=97; SIBS-II, n=56). In SIBS-I, the KL-VS allele conferred a relative odds of 1.90 (95% confidence interval 1.21-2.98) for occult CAD, after adjusting for familial intraclass correlations (P<.005). Logistic regression modeling, incorporating known CAD risk factors, demonstrated that the KL-VS allele is an independent risk factor (P<.019) and that the imposed risk of KL-VS allele status is influenced by modifiable risk factors. Hypertension (P<.022) and increasing high-density lipoprotein cholesterol (HDL-C) levels (P<.022) mask or reduce the risk conferred by the KL-VS allele, respectively, whereas current smoking (P<.004) increases the risk. Remarkably concordant effects of the KL-VS allele and modifying factors on the risk of occult CAD were seen in SIBS-II. These results demonstrate that the KL-VS allele is an independent risk factor for occult CAD in two independent high-risk samples. Modifiable risk factors, including hypertension, smoking status, and HDL-C level, appear to influence the risk imposed by this allele.
Donate-Correa J, Ferri C, Mora-Fernandez C, Perez-Delgado N, Gonzalez-Luis A, Navarro-Gonzalez J Cardiovasc Diabetol. 2024; 23(1):314.
PMID: 39182114 PMC: 11344929. DOI: 10.1186/s12933-024-02393-x.
Huang C, Guan Y, Chen L, Xu Y, Yang H Lipids Health Dis. 2024; 23(1):251.
PMID: 39153988 PMC: 11330610. DOI: 10.1186/s12944-024-02242-6.
Mendoza-Carrera F, Farias-Basulto A, Gomez-Garcia E, Rizo De la Torre L, Cueto-Manzano A, Cortes-Sanabria L J Diabetes Metab Disord. 2024; 23(1):1125-1131.
PMID: 38932797 PMC: 11196432. DOI: 10.1007/s40200-024-01398-3.
Determination of the Relationship Between DNA Methylation Status of and Genes With Hypertension.
Osum M, Tosun O, Birtan H, Kalkan R Balkan J Med Genet. 2024; 26(2):41-50.
PMID: 38482265 PMC: 10932598. DOI: 10.2478/bjmg-2023-0024.
Collins K, Ambrosio F, Rogers R, Lang W, Schelbert E, Davis K Front Aging. 2023; 4:1213228.
PMID: 37457921 PMC: 10347392. DOI: 10.3389/fragi.2023.1213228.